Free shipping on all orders over $ 500

Talacotuzumab

Cat. No. M24827

All AbMole products are for research use only, cannot be used for human consumption.

Talacotuzumab Structure
Synonym:

JNJ 56022473; CSL 362

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models.

Chemical Information
CAS Number 1826831-79-1
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] John Devin Peipert, et al. J Geriatr Oncol. Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemia

[2] Pau Montesinos, et al. Leukemia. Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

[3] Anne Sophie Kubasch, et al. Leukemia. Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents

Related IL Receptor/Related Products
IL-15-IN-1 

IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM.

IL-17 modulator 3 

IL-17 modulator 3 is an IL-17 modulator.

IL-17 modulator 4 

IL-17 modulator 4 is a proagent of IL-17 modulator 1.

IL-17A modulator-3 

IL-17A modulator-3 is a IL-17A modulator.

IL-17 modulator 4 sulfate 

IL-17 modulator 4 sulfate is a proagent of IL-17 modulator 1.

  Catalog
Abmole Inhibitor Catalog




Keywords: Talacotuzumab, JNJ 56022473; CSL 362 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.